More MS news articles for July 2002


Report From the International Congress of Ophthalmology

Results from the Optic Neuritis Treatment Trial[4] provided evidence to show: improvement to normal was part of the natural history of the disease for most; high-dose intravenous steroids plus low doses orally accelerated recovery; low-dose systemic steroids alone were harmful; detection of white lesions in the paraventricular regions increased the risk of subsequent multiple sclerosis; and steroids plus interferon beta-1A resulted in fewer new or growing intracranial lesions. We also know now that optic nerve defenestration does not help nonarteritic anterior ischemic optic neuropathy.

Medscape Ophthalmology 3(2), 2002.

© 2002 Medscape